Zepp Health Corporation to Report Fourth Quarter and Full Year 2025 Financial Results on March 15, 2026
MWN-AI** Summary
Zepp Health Corporation, a prominent global leader in smart wearables and health technology, is set to announce its unaudited financial results for the fourth quarter and full year of 2025 on March 15, 2026. The announcement will be followed by a conference call at 9:30 p.m. ET, allowing investors and analysts to engage directly with management. For those wishing to join the call, several access methods are available, including toll-free numbers for both domestic and international listeners.
Founded in 2013 as Huami Corp., Zepp Health rebranded in February 2021 to underscore its focus on health and wellness. The company has made significant strides in the wearable technology sector, empowering individuals to enhance their health and fitness through products under its well-known brands, including Amazfit, Zepp Clarity, and Zepp Aura. The innovative Zepp Digital Management Platform, bolstered by proprietary technologies such as Zepp OS, AI chips, and biometric sensors, provides users with actionable insights and continuous guidance tailored to their wellness objectives.
Having shipped over 200 million units globally and with a presence in more than 90 countries, Zepp Health has cultivated a diverse user base. By leveraging its advanced data algorithms, the company offers a unique combination of health technology and consumer engagement.
As Zepp Health prepares to share its financial performance data, stakeholders can look forward to insights on the company's ongoing growth strategies and outlook for the future. For further information, interested parties can access the live webcast on the company's investor relations website.
MWN-AI** Analysis
As Zepp Health Corporation prepares to report its fourth quarter and full-year 2025 financial results on March 15, 2026, investors should consider several key factors that could influence the company's stock performance and position in the smart wearables market.
With a strong emphasis on health technology and a focus on user-centered products, Zepp has established a significant foothold in the wearable tech sector. As of now, the company has shipped over 200 million units globally and operates in over 90 countries, showcasing its broad market reach. Observing trends leading up to the earnings report, stakeholders should pay particular attention to consumer demand for health-focused products, as the fitness and wellness industry continues to thrive in a post-pandemic world. This demand provides potential for revenue growth, particularly for innovative product lines like Amazfit and Zepp Aura.
Moreover, analysts ought to examine any changes in competitive dynamics within the market. With companies such as Apple and Fitbit continuously evolving their offerings, Zepp's ability to remain competitive will be crucial. Investors should track updates on technical innovations or partnerships that may bolster Zepp's market standing.
Historically, Zepp’s quarterly reports have influenced stock volatility, so market participants should prepare for potential fluctuations post-earnings release. Key metrics to observe will include gross margins, revenue growth rates, and guidance for future quarters.
Overall, while Zepp Health has positioned itself well within the health technology landscape, investors should approach the upcoming earnings release with cautious optimism, monitoring external factors and internal performance indicators that could dictate the company's short-term trajectory. Keeping an eye on market sentiment and peer performance can also provide additional context for investment decisions.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Earnings Call Scheduled for 9:30 p.m. ET on March 15, 2026
MILPITAS, Calif., March 10, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced that it will report its fourth quarter and full year 2025 unaudited financial results on Sunday, March 15, 2026.
Management will hold a conference call at 9:30 p.m. Eastern Time on Sunday, March 15, 2026. Listeners may access the call by dialing:
US (Toll Free): | +1-888-346-8982 | |
International: | +1-412-902-4272 | |
Mainland China (Toll Free): | 400-120-1203 | |
Hong Kong (Toll Free): | 800-905-945 |
Participants should dial in at least 10 minutes before the scheduled start time and ask to be connected to the call for "Zepp Health Corporation."
Additionally, a live and archived webcast of the conference call will be available at http://ir.zepp.com.
A telephone replay will be available one hour after the end of the conference until March 22, 2026 by dialing the following telephone numbers:
US (Toll Free): | +1-855-669-9658 |
International: | +1-412-317-0088 |
Replay Passcode: | 8917498 |
About Zepp Health Corporation
Zepp Health Corporation (NYSE: ZEPP) is a global smart wearable and health technology leader, empowering users to live their healthiest lives by optimizing their health, fitness, and wellness journeys through its leading consumer brands, Amazfit, Zepp Clarity and Zepp Aura. Powered by its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors and data algorithms, Zepp delivers cloud-based 24/7 actionable insights and guidance to help users attain their wellness goals. To date, Zepp has shipped over 200 million units, and its products are available in more than 90 countries and regions. Founded in 2013 as Huami Corp., the Company changed its name to Zepp Health Corporation in February 2021 to emphasize its health focus with a name that resonates across languages and cultures globally. Zepp has team members and offices across globe, especially in Europe and USA regions.
For more information on Zepp Health and its products, please visit www.zepp.com.
For investor and media inquiries, please contact:
Zepp Health Corporation
Grace Yujia Zhang
Email: ir@zepp.com
Piacente Financial Communications
Email: zepp@tpg-ir.com
SOURCE Zepp Health Corp.
FAQ**
How did Zepp Health Corporation American Depositary Shares ZEPP perform in terms of revenue growth for the fourth quarter and full year 2025 compared to previous years, and what factors contributed to this performance?
What key developments or innovations in product offerings did Zepp Health Corporation American Depositary Shares ZEPP implement in 20that are expected to impact future financial results?
Can you discuss any challenges Zepp Health Corporation American Depositary Shares ZEPP faced in 2025 regarding supply chain or market competition, and how these were addressed?
What is the outlook for Zepp Health Corporation American Depositary Shares ZEPP for 2026 in terms of anticipated market trends and strategic initiatives to enhance growth?
**MWN-AI FAQ is based on asking OpenAI questions about Zepp Health Corporation American Depositary Shares (NYSE: ZEPP).
NASDAQ: ZEPP
ZEPP Trading
8.07% G/L:
$20.09 Last:
45,697 Volume:
$18.85 Open:



